We use cookies to provide you a better experience. By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy.

STF-logo (1)
Paul Matteis

Paul Matteis

Managing Director, Head of Therapeutics Research

Biotechnology

Boston

[email protected] | (617) 488-4485 | v-Card | View Coverage

Paul Matteis joined Stifel in 2018.  Based out of the firm’s Boston office, he serves as a Managing Director and Head of Biotech Research.

Previously, Paul was a Senior Biotechnology Analyst covering small-cap and mid-cap companies at Leerink, with a focus on neuroscience, central nervous system and rare disease. Before this, he was a Research Assistant at the Harvard Division of Sleep Medicine at Brigham & Women's Hospital.

Paul was named a “Runner Up” in Small/Mid Cap Biotechnology in 2019-2023, as well as a "Rising Star" by Institutional Investor in both 2015 and 2016, as part of the publication's All-America Research Team rankings.  He attended Skidmore College in New York, where he studied Psychology and Pre-Medical Sciences and graduated Phi Beta Kappa.